3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Thrombocytopenia
14
Leukemia, Myeloid, Acute
5
Leukemia
3
Jacobs syndrome
3
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Sarcoma
1
Recurrence
1
Purpura, Thrombocytopenic, Idiopathic
1
Primary Myelofibrosis
1
Pathologic Complete Response
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Chemotherapy-induced Thrombocytopenia
1
Blast Crisis
1
Anemia, Refractory, with Excess of Blasts
1
Anemia
1
Interventions
Cyclophosphamide
31
fludarabine phosphate
28
Mycophenolic Acid
21
Cyclosporine
21
Peripheral Blood Stem Cell Transplantation
19
Whole-Body Irradiation
17
Antilymphocyte Serum
17
Cord Blood Stem Cell Transplantation
15
Busulfan
15
Tacrolimus
13
Radiotherapy
11
Filgrastim
11
Methotrexate
9
Methylprednisolone
8
Melphalan
8
fludarabine
6
Etoposide
5
Epoetin Alfa
5
Cytarabine
4
Thiotepa
3
Therapeutics
3
Darbepoetin alfa
3
thymoglobulin
2
merphos
2
Vorinostat
2
Immunoenzyme Techniques
2
Granulocyte Colony-Stimulating Factor
2
Flow Cytometry
2
Cyclosporins
2
Bortezomib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
eltrombopag
×
Classical hematology
×
Clear all
NCT01500538
2016-02-15
VEIL
Peter MacCallum Cancer Centre, Australia
Phase 2
Terminated
1 enrolled